Do you want to read an article? Please log in or register.
Patient Reported Outcome Measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review
Pneumonia
RECOMMENDED
Related content
RECOMMENDED
PneumoniaRespiratory Tract Infection
Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
Montes-Andujar L, Tinoco E, Baez-Pravia O, Martin-Saborido C, Blanco-Schweizer P, Segura C, Prol Silva E, Reyes V, Rodriguez Cobo A, Zurdo C, Angel V, Varona O, Valero J, Suarez Del Villar R, Ortiz G, Villanueva J, Menéndez J, Blanco J, Torres A, Cardinal-Fernández PA
doi: 10.1136/thoraxjnl-2019-214054
RECOMMENDED
Pneumonia
Adherence to Treatment Guideline Improves Patient Outcomes in a Prospective Cohort of Adults Hospitalized for Community-Acquired Pneumonia
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Open Forum Infect Dis.
Lui G, To HKW, Lee N, Chan RWY, Li T, Wong RYK, Hui DSC, Ip M
doi: 10.1093/ofid/ofaa146.
RECOMMENDED
Pneumonia
Effectiveness of a Bundled Intervention Including Adjunctive Corticosteroids on Outcomes of Hospitalized Patients With Community-Acquired Pneumonia: A Stepped-Wedge Randomized Clinical Trial
JAMA Intern Med.
Lloyd M, Karahalios A, Janus E, Skinner EH, Haines T, De Silva A, Lowe S, Shackell M, Ko S, Desmond L, Karunajeewa H, Improving Evidence-Based Treatment Gaps and Outcomes in Community-Acquired Pneumonia (IMPROVE-GAP) Implementation Team at Western Health.
doi: 10.1001/jamainternmed.
Pneumonia
Fibroblast Growth Factor-21 Predicts Outcome in Community-Acquired Pneumonia Secondary Analysis of two Randomized Controlled Trials
Eur Respir J.
Ebrahimi F, Wolffenbuttel C, Blum CA, Baumgartner C, Mueller B, Schuetz P, Meier C, Kraenzlin M, Christ-Crain M, Betz MJ
doi: 10.1183/13993003.00973-2018.
Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in critically-ill patients: systematic review
Farm Hosp.
Carballo N, De Antonio-Cuscó M, Echeverría-Esnal D, Luque S, Salas E, Grau S
doi: 10.7399/fh.2017.41.2.10591.
COMMENTED
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia
Respir Med.
Arnold FW, Lopardo G, Wiemken TL, Kelley R, Peyrani P, Mattingly WA, Feldman C, Gnoni M, Maurici R, Ramirez JA; Community-Acquired Pneumonia Organization (CAPO)
doi: 10.1016/j.rmed.2018.05.020.
RECOMMENDED
COPDPneumonia
Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology & outcomes
Clin Microbiol Infect.
Bordon J, Slomka M, Gupta R, Furmanek S, Cavallazzi R, Sethi S, Niederman M, Ramirez JA, University of Louisville Pneumonia Study Group.
doi: 10.1016/j.cmi.2019.06.025.
RECOMMENDED
Pulmonary Fibrosis
Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
McLeod C, Wood J, Schultz A, Norman R, Smith S, Blyth CC, Webb S, Smyth AR, Snelling TL
doi: 10.1016/j.jcf.2020.08.015
RECOMMENDED
Bronchi
Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Crichton ML, Dudgeon EK, Shoemark A, Chalmers JD
doi: 10.1183/13993003.03156-2020